EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,128,000 | -26.8% | 36,326 | -3.3% | 0.02% | -13.6% |
| Q1 2022 | $1,542,000 | +6.4% | 37,564 | +12.7% | 0.02% | +15.8% |
| Q4 2021 | $1,449,000 | -21.4% | 33,338 | -9.5% | 0.02% | -26.9% |
| Q3 2021 | $1,844,000 | -20.1% | 36,832 | +0.5% | 0.03% | -21.2% |
| Q2 2021 | $2,309,000 | -7.2% | 36,664 | +36.9% | 0.03% | -15.4% |
| Q1 2021 | $2,487,000 | +13.1% | 26,773 | +9.1% | 0.04% | +5.4% |
| Q4 2020 | $2,198,000 | -13.2% | 24,536 | +0.1% | 0.04% | -24.5% |
| Q3 2020 | $2,532,000 | -31.9% | 24,508 | -47.9% | 0.05% | -36.4% |
| Q2 2020 | $3,717,000 | +59.0% | 47,014 | +16.3% | 0.08% | +35.1% |
| Q1 2020 | $2,338,000 | +21.2% | 40,408 | +13.0% | 0.06% | +39.0% |
| Q4 2019 | $1,929,000 | +2.4% | 35,762 | -0.8% | 0.04% | -2.4% |
| Q3 2019 | $1,884,000 | +6.2% | 36,036 | -1.8% | 0.04% | +7.7% |
| Q2 2019 | $1,774,000 | – | 36,713 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
| GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
| Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
| ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
| RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
| NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
| Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |